In-Vitro Colorectal Cancer Screening Tests Market Share

Report ID: GMI451
   |
Published Date: October 2021
 | 
Report Format: PDF

Download Free PDF

In-Vitro Colorectal Cancer Screening Tests Market Share

Some of the major companies operating in the in-vitro colorectal cancer screening tests market are:

  • Abbott Molecular
  • Epigenomics AG
  • Novigenix
  • Sysmex Corporation
  • Eiken Chemical
  • Quest Diagnostics
  • BioMarCare Technologies
  • Randox Laboratories
  • OncoCyte Corporation-Bio time
  • Exact Sciences Corporation
  • Immunostics.

These prominent leaders concentrate on adoption of several initiatives such as strategic agreements, new product launch, mergers & acquisition for business expansion. Furthermore, these participants are heavily investing in research that enables them to launch advanced products and channelize maximum market share.

Authors: Mariam Faizullabhoy ,
Frequently Asked Question(FAQ) :
How big is the U.S. in-vitro colorectal cancer screening tests market?
The U.S. market is estimated to exceed USD 392 million through 2027 due to the rising prevalence of obesity and CRC, along with the presence of favorable reimbursement scenarios in the country.
What is in-vitro colorectal cancer screening tests market worth?
How will the demand for in-vitro colorectal cancer screening tests fare across hospitals?
Which tests are used for in-vitro colorectal cancer screening?
Related Reports
    Authors: Mariam Faizullabhoy ,
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2020

    Companies covered: 12

    Tables & Figures: 294

    Countries covered: 18

    Pages: 150

    Download Free PDF

    Top